In a large Phase III trial, GlaxoSmithKline's Arexvy substantially reduced people's risk of severe complications from respiratory syncytial virus infection.
“Today’s approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA’s continued commitment to facilitating the development of safe and effective vaccines for use in the United States,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, in aThere are still some important questions left regarding Arexvy.
and joint stiffness/pain. But Arexvy might also pose a risk of rare but serious side effects as well. In one smaller study, which had some people also take an approved flu vaccine at the same time, two people who took the vaccine combination developed acute disseminated encephalomyelitis , a type of inflammation that affects the brain and spinal cord; one, a condition where the immune system attacks nerve cells, causing muscle weakness and sometimes paralysis.
While GSK’s RSV vaccine is the first to reach the public, it’s unlikely to be the last. Moderna’s RSV
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Baca lebih lajut »
FDA approves first vaccine for RSV, a moment six decades in the making | CNNAfter a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Baca lebih lajut »
FDA approves first RSV vaccine to protect older adultsUp to 10,000 deaths and 160,000 hospitalizations a year are caused by RSV.
Baca lebih lajut »
US approves 1st vaccine for RSV after decades of attemptsThe U.S. has approved the first vaccine for RSV, shots to protect older adults
Baca lebih lajut »
1st RSV vaccine for older adults in US cleared by FDA in historic approvalThe U.S. Food and Drug Administration has approved the first RSV vaccine in the U.S.
Baca lebih lajut »